Archive for the ‘Skin Cancer’ category

An Alternative to Mohs Surgery

May 10th, 2011

Did you know that surgery, typically Mohs surgery is not the only way to successfully treat skin cancers? Surgery on the nose, ears, eyelids or lips may cause disfigurement or require reconstructive surgery under a general anesthetic to maintain the natural appearance. Brachytherapy with the Flexitron system is an effective alternative treatment for BCC (Basel Cell Carcinoma) and SCC (Squamous Cell Carcinoma) skin cancer and avoids the need for reconstructive surgery. It also has its advantages over surgery for patients with a large number of lesions, elderly patients, or patients who are otherwise inoperable, and advantages over external beam radiotherapy as it requires shorter treatment times and less side effects.

At The Farber Center for Radiation Oncology we offer a dedicated suite where patients receive HDR (high dose rate) Brachytherapy with the Flexitron system. The Flexitron applicator facilitates close contact between the brachytherapy radiation source and the skin. This helps ensure conformity of the radiation dose to the tumor to provide excellent cosmetic results and clinical efficacy. The Treatment is typically twice a week for up to 4 weeks, and allows patients to return to work or home the same day of treatment.

Dr. Manny Alvarez

Please take a look at Dr. Manny, the senior managing health editor for Fox News and his coverage of an alternative to Mohs at The Farber Center. CLICK HERE or press play below.

Share

10K Raised for The Revlon Run/Walk by The Farber Center Team

May 3rd, 2011

Saturday morning we completed our first Revlon Run Walk for Women as The Farber Center Team and raised $10,000.

The Run/Walk is co-sponsored by the Entertainment Industry Foundation, so celebrities always kick off the race with motivational speeches. This year’s guests included Keesha Cole, Jessica Alba, Jimmy Fallon, Nate Berkus and Doctor Oz.

(L-R) Nate Berkus,Jessica Alba,Dr. Mehmet Oz, Jessica Biel and Jimmy Fallon attend the 14th annual Entertainment Industry Foundation Revlon Run/Walk for Women on April 30, 2011 in New York City.

The Revlon Run always starts in Times Square and ends in Central Park. Money raised from the New York event will help support local New York-based cancer organizations including: The Actors’ Fund, Albert Einstein Cancer Center, Cancer Care, Gilda’s Club NYC, Memorial Sloan-Kettering Cancer Center, National Coalition for Cancer Survivorship, Ovarian Cancer National Alliance, William F. Ryan Community Health Center, EIF’s Women’s Cancer Programs.

Dr. Marnee Spierer, Marina Higgins, Dr. Leonard Farber

(L-R) Dr. Marnee Spierer, Team Captain Marina Higgins, Dr. Leonard Farber

Here is more coverage of the Revlon Run/Walk: Fox News Coverage

Share

The Farber Center Walks for Cancer

April 18th, 2011

Marina Higgins VP Argo Real Estate

On April 30th, The Farber Center Team lead by our patient Marina, will walk for the 14th Annual Industry Foundation Revlon Run/Walk in New York City.
The EIF Revlon Run Walk was created in 1994 through the committed and collective efforts of the Entertainment Industry Foundation, Lilly Tartikoff and Ronald O. Perelman. The EIF Revlon Run/Walk for Women has grown to become one of the nation’s largest 5K fundraising events. To date, the Run/Walks (in Los Angeles and New York) have distributed over $60 million for cancer research, treatment, counseling and outreach programs. Thanks in part to these funds, new treatments are being developed and lives are being saved.

Your donation will help fund important research into the cause and cure of women’s cancers, prevention, education and support service programs.

So please donate if you can. Here is the link: DONATE

Team t-shirt by our friend Dan McClure: his email:dan@eastcoastsportswear.com

Share

Co-Payment Help for Cancer Patients

February 28th, 2011

The CancerCare Co-Payment Assistance Foundation is a not-for-profit organization established in 2007 to address the needs of individuals who cannot afford their insurance co-payments to cover the cost of medications for treating cancer.

WHO IS ELIGIBLE?
The CancerCare Co-Payment Assistance Foundation takes into account a person’s financial and insurance situation when determining who is eligible for assistance.

The criteria used to determine if you are eligible are:

Financial Information
Individuals or families with incomes of up to four times the federal poverty level may qualify. See the poverty level chart below. The Foundation may also consider the cost of living in your particular city or state.

Diagnosis and Treatment
You must be diagnosed with one of the cancer types that the Foundation covers. This is a listing of diagnoses they currently cover:
Breast Cancer
Colon or Colorectal Cancer
Gastric Cancer
Glioblastoma
Head and Neck Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cell Cancer

Your diagnosis must be verified by a doctor. Your doctor must complete and sign their physician verification form.
You must receive treatment dispensed in the United States, and the medication that you are taking must be approved by the Food and Drug Administration (FDA) for cancer.

Insurance Coverage
You must be covered by private insurance or an employer-sponsored health plan, —or—
Have Medicare Part B, Medicare Part D, Medicare Supplementary Health Insurance (“Medigap”) or Medicare Advantage Plan
If you are uninsured (do not have any insurance or medical plan that covers prescription medication) you are not eligible for co-payment assistance; however, we encourage you to contact us so that we can refer you to other organizations or patient assistance programs.
The Foundation grants assistance on a first-come, first-served basis, to the extent that funding is available.

HOW IT WORKS
Step 1: Apply
Call 1-866-55-COPAY to determine if you are eligible and begin the application process.
Step 2: Award Determination
They will send you a form to complete and return.
They will send you a form that your doctor will need to complete and return.
If approved, you will receive an Award Determination letter by mail with instructions for accessing your award.

Important Note: The Foundation will only send an application form to you after you call 1-866-552-6729 to speak with one of their specialists so that they can determine if you are eligible to apply.

Share

Connect with family and friends during a health challenge

January 31st, 2011


When you find yourself diagnosed with an illness, your family and friends can be a pillar of strength.

People going through cancer treatments should never have to go it alone. Throughout the process, family members need to stay strong.

Unfortunately, contracting a secondary illness while fighting cancer can seriously hurt your ability to fight the disease. So when you are unable to go meet friends or be with family, you can be open and honest about why, and still connect in a personal way.

CaringBridge websites offer a personal and private space to communicate and show support, saving time and emotional energy when health matters most. The websites are easy to create and use. Authors add health updates and photos to share their story while visitors leave messages of love, hope and compassion in the guestbook.

No one likes to sit on the sidelines, but being honest about why you’re doing so will help keep your friends and family close. To see how it works click here: CaringBridge

Share

FLEXITRON BY Nucletron ARRIVES at The Farber Center for Radiation Oncology

January 24th, 2011

The First Radiation Center Offering this Cutting-Edge technology in New York City.

The Farber Center for Radiation Oncology has become the first treatment center in New York City——to treat skin cancer patients with Flexitron, an advanced HDR brachytherapy delivery system that brings a whole new world of safety to brachytherapy, providing to-the-millimeter accuracy while allowing physicians to administer higher, more concentrated doses of radiation directly to cancer cells. . Flexitron is the most advanced afterloader ever offered by Nucletron – the acknowledged leader in brachytherapy-based precision radiation oncology.
Dr. Leonard Farber, Radiation Oncologist and founder of the Farber Center, is currently treating the first skin cancer patient to undergo HDR Brachytherapy treatment at the center with the Flexitron system. In keeping with The Farber Center’s commitment to state-of-the-art technology and patient comfort, Flexitron represents cutting-edge, minimally invasive care that puts the patient first.

Skin cancers can often be successfully treated by the surgical removal of the cancerous tumor typically Mohs surgery. Surgery on the nose, ears, eyelids or lips may cause disfigurement or require reconstructive surgery under a general anesthetic to maintain the natural appearance. Brachytherapy with the Flexitron system is an effective alternative treatment for BCC and SCC skin cancer and avoids the need for reconstructive surgery. It also has its advantages over surgery for patients with a large number of lesions, elderly patients, or patients who are otherwise inoperable, and advantages over external beam radiotherapy as it requires shorter treatment times and less side effects.

The Flexitron applicator facilitates close contact between the brachytherapy radiation source and the skin. This helps ensure conformity of the radiation dose to the tumor to provide excellent cosmetic results and clinical efficacy. Below is a picture of a squamos cell skin cancer before and after radiation treatment.

“We’re so pleased to be able to offer this truly revolutionary treatment at The Farber Center,” says Dr. Farber. “HDR Brachytherapy with Flexitron offers an ideal treatment for our patients in New York, as it is a short, targeted, non-invasive course that provides a superior level of care and lets our patients live their lives with minimal interference.”

At a dedicated suite at the The Farber Center, patients will receive HDR Brachytherapy with the Flexitron system treatment typically twice a week for up to 4 weeks, and allow patients to return to work or home the same day of treatment.

Share

Tribeca Citizen Covers The Farber Center

December 14th, 2010

I had the great pleasure to meet Erik Torkells the other day. Erik is the founder of Tribeca Citizen which is a website dedicated to all things Tribeca. Erik got the idea for Tribeca Citizen after he quit his job in the summer of 2008. He lived in the neighborhood since 2003, but after taking Howard ( his pug), on much longer walks with his new found time, he discovered he had all sorts of questions: What was filming on Duane Street? What will that huge new Frank Gehry building look like? What is David Bouley up to now? When he couldn’t find a website with the answers, he began to envision one.

Erik discovered us on one of those walks and decided that everyone should know that there was an amazing alternative for cancer patients in need of radiation therapy. Please Click here to read the story www.tribecacitizen.com.

Share

Cancer Fundraiser

June 29th, 2010

The Farber Center for Radiation Oncology

Presents

ROCKS AGAINST CANCER

A Fundraising Event for Entertainment Industry Foundation
benefiting EIF Cancer Programs.

Thursday, Sept 16th 7pm to 11pm

BLACK TIE ROCK & ROLL STYLE!

To purchase tickets or donate click here: Rocks Against Cancer Tickets

The event will take place at the Angel Orensanz Foundation for the Arts, situated on 172 Norfolk Street in the former Ansche Chesed Synagogue, the venue boasts superbly maintained mid-19th century architecture.

The lounge-style space will feature cocktails and food as well as performances by The Rotten Hill Gang, a six-piece band from London fronted by Mick Jones of The Clash. Eclectic Method featuring London natives Jonny Wilson, Ian Edgar and Geoff Gamlen – who helped pioneer the emerging art of audio-visual mixing since first cutting U2’s Mysterious Ways music video with the Beastie Boys’ Intergalactic as an experiment back in 2002 will close out the night.

The event also includes a silent auction of jewelry by Stephen Webster—three-time winner of the “British Luxury Jeweller of the Year” award and 2008 winner of “UK Jewellery Brand of the Year”—including specially designed bracelets supporting the fight against cancer with net proceeds benefiting EIF’s Cancer programs. Webster is widely known as the jeweler to the stars; his celebrity client list includes Madonna, Elizabeth Taylor, Jennifer Lopez, Kim Cattrall, and Christina Aguilera among others.

Some of EIF’s cancer programs include: Stand Up To Cancer (SU2C)Woman’s Cancer Research Fund, Brains on Bikes, Right Action for Woman, and the National Colorectal Research Alliance

If you are arriving from out of town please contact the Smyth – part of the Thompson Hotels at 85 West Broadway phone: 212.587.7000. We have reserved rooms at a special rate under the group name Rocks Against Cancer.

A special thanks to our current sponsors at the time this blog went out: Stephen Webster, Matthew Robbins Desings, Svendka, Warren Tricomi, and Elekta Inc.

Share

Skin cancer prevention

May 19th, 2010

March 4, 2008 by Admiral Baconsquatch

Although the sun has not been shining lately in NYC, it is skin cancer prevention and detection month. Skin cancer is the most common of all cancer types. More than 1 million skin cancers are diagnosed each year in the United States. That’s more than cancers of the prostate, breast, lung, colon, uterus, ovaries, and pancreas combined.

The good news is that you can do a lot to protect yourself and your family from skin cancer. Most skin cancers are caused by too much exposure to ultraviolet (UV) rays. There are two types of rays to be concerned with, UVB and UVA. UVB rays cause a much greater risk of skin cancer than UVA. However, UVA rays cause aging, wrinkling, and loss of elasticity. UVA also increases the damaging effects of UVB, including skin cancer and cataracts. Much of this exposure comes from the sun, but some may come from man-made sources, such as indoor tanning lamps.

What’s important is understanding how to pick the right sunscreen. SPF is the universal measurement of UVB protection. SPF (sun protection factor): measures the length of time a product protects against skin reddening from UVB, compared to how long the skin takes to redden without protection. If it takes 20 minutes without protection to begin reddening, using an SPF 15 sunscreen theoretically prevents reddening 15 times longer — about 5 hours. (Actually, it may take up to 24 hours after sun exposure for redness to become visible.) To maintain the SPF, reapply sunscreen every two hours and right after swimming.

The Skin Cancer Foundation recommends SPF’s of at least 15, which block 93 percent of UVB. While SPF’s higher than 30 block only 4 percent more UVB, they may be advisable for sun-sensitive individuals, skin cancer patients, and people at high risk of developing skin cancer. They also allow some margin for error if too little sunscreen is applied.

Our suntan lotions are good at screening out the sun’s UVB rays — the ones that cause sunburn and skin cancers — but most people don’t realize their sunscreens don’t offer much protection against UVA rays.

One product in particular that has both UVB and UVA protection is La Roche-Posay Anthelios XL Lait SPF. The reason is that is contains Mexoryl. Mexoryl MEXORYL™ SX is the most effective FDA-approved organic filter designed to protect against short UVA rays (maximum absorption at 344nm) with high photostability, a key factor in sunscreen protection efficacy. This high photostability means the sunscreen will maintain a higher UVA protective ability longer and not degrade as quickly as other FDA approved UVA filters when exposed to the sun. People are happily protecting themselves with Mexoryl on the beaches of Rio de Janeiro, the streets of Paris, in Canada, Mexico and Australia. It has just recently been approved by the FDA for use in the US.

The safety and efficacy data for Anthelios SX included information from 28 studies in over 2500 patients, ranging in age from 6 months to over 65 years old. In addition, the contribution of each of the active ingredients to sun protection was studied. Side effects reported during clinical studies were infrequent and non-serious. The most common side effects in patients were acne, dermatitis, dry skin, eczema, abnormal redness, itching, skin discomfort and sunburn.

Share

Switch to our mobile site